The metastasis of breast cancer to the axillary lymph nodes represents a crucial aspect of disease progression and prognostic evaluation. The presence of metastases in the axillary lymph nodes is a key indicator that breast cancer is in an advanced stage, which can influence the therapeutic approach and the patient's prognosis. For this reason, we conducted a study aimed at examining the factors that contribute to the presence of metastases in lymph nodes in our female population. This research represents a prospective study conducted at the Institute of Oncology of Vojvodina in Sremska Kamenica. The study included 72 female participants diagnosed with breast cancer who underwent surgery at the Institute of Oncology of Vojvodina and had not received preoperative chemotherapy or radiation therapy. Initially, anamnestic data were collected from the participants, followed by a pathohistological analysis of the tumor tissue samples, including immunohistochemical analysis. We examined the influence of age, tumor size, activity of estrogen, progesterone, and HER2 receptors (human epidermal growth factor receptor-2)  in tumors, as well as the occurrence of menarche and breastfeeding duration, on the presence of metastases in axillary lymph nodes. The results of binary logistic regression showed that the only significant predictor for the presence of metastases in axillary lymph nodes was tumor size (p=0.01, Wald=6.57, and Exp(B)=1.11), while the other examined predictors were not statistically significant (p>0.05). In our study population, the size of the breast cancer was crucial for the presence of metastases in the axillary lymph nodes.

This research was supported by the Science Fund of the Republic of Serbia, #7750238, Exploring new avenues in breast cancer research: Redox and metabolic reprogramming of cancer and associated adipose tissue - REFRAME.

Breast cancer is one of the most common malignant diseases in women worldwide. Since the involvement of axillary lymph node metastases is related to the poor prognosis of these patients, the objective of our study was to investigate the association between breast tumor size and the presence of axillary lymph node metastases. Our research was performed at the Institute of Oncology of Vojvodina in Sremska Kamenica. The study consisted of 72 women diagnosed with breast cancer aged between 29 and 84 years (average age: 59.04±10.87 years) whose breast tumor was surgically removed at the Institute of Oncology of Vojvodina. Patients who received preoperative chemo- or radiotherapy were excluded from the study. The data concerning breast tumor size and the presence of axillary lymph nodes in these women was obtained from the reports of Department of Pathoanatomical Diagnostics of the Institute of Oncology of Vojvodina. The results of our study indicated to positive, statistically significant moderate correlation between the size of breast tumor and the presence of axillary lymph node metastases (r=0.32, p=0.01). Receiver operating curve (ROC) analysis notified that cut-off value of breast tumor size for the presence of axillary lymph node metastasis was 22.5 mm (AUC=0.70, p=0.01). In our investigation, women with breast tumor size of 22.5 mm or larger were predisposed to the presence of axillary lymph node metastases.

This research was supported by the Science Fund of the Republic of Serbia, #7750238, Exploring new avenues in breast cancer research: Redox and metabolic reprogramming of cancer and associated adipose tissue - REFRAME.